The company from Pomezia (Rome) is a forerunner for vaccines: “Production has started, we will be ready in September”
Interview with Piero Di Lorenzo, the entrepreneur at the head of IRBM, the Italian company that collaborates with the Oxford University. “We have shown that betting on scientific research is possible in Italy”. Piero Di Lorenzo bought IRBM from the multinational Merck eleven years ago, but he would never have thought that now, with the same money, he would not even buy the gate of his company. “The bet is won”. Di Lorenzo talks about his collaboration with Oxford and explains how the vaccine has been developed and how close it really is.
Article by Paolo Russo published on lastampa.it – 14/06/2020
Read the original article on lastampa.it